Search clinical trials for: amendement du facteur C5 du complément

Total 373901 results

Bristol-Myers Squibb

Terminated

Study to Evaluate the Safety, Tolerability, PK, and PD of BMS-986090 in Healthy Subjects

Healthy Adult Volunteers

United States
Loma Linda University

Completed

Effects of Soy Based Dietary Supplements on Cardiometabolic Risk Factors.

Obesity | Cardiovascular Risk Factors

United States
Hoffmann-La Roche

Completed

A Study of the Correlation Between Pharmacokinetic and Pharmacodynamic Parameters of CellCept (Mycophenolate Mofetil).

Kidney Transplantation

Italy
Ulsan University Hospital
Cooperative Study Group A for Hematology

Unknown

Lenalidomide After Failure of Hypomethylating Agents in Myelodysplastic Syndrome (VIOLET)

Myelodysplastic Syndrome

Korea, Republic of
University of Copenhagen

Completed

Salivary IgA and Cytokines Response to Dietary Supplementation of Lactobacillus Reuteri

Periodontitis | Dental Caries

Denmark
M.D. Anderson Cancer Center
Novartis

Completed

High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML)

Leukemia, Myeloid, Chronic

United States
Heba Allah Ali Abd El-Halim Mabrouk
Tanta University

Unknown

Alpha Lipoic Acid as an Adjuvant Treatment in Acute Phosphide Poisoning (ALA)

Toxicity
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Research Study To Test How Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given By Subcutaneous Injection (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)

Neutropenia (Low White Blood Cell Count)

United States
Loughborough University

Completed

Resistance Exercise, Recovery Drinks and Appetite

Active Population
Roswell Park Cancer Institute
National Cancer Institute (NCI); Teva Pharmaceutical Industries, Ltd.

Terminated

Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic... and other conditions

United States
Shenzhen Hornetcorn Bio-technology Company, LTD

Unknown

Clinical Efficacy and Safety of Dendritic Cytotoxic Lymphocyte(DC-CTL) Cell Infusion in NSCLC Patients

NSCLC

China
October 6 University

Completed

Effect of Omega 3 on Periodontitis in Postmenopausal Women

Chronic Periodontitis
Universidad Autonoma de Madrid
Sanofi

Completed

Study on Nutrition and Cardiovascular Risk in Spain. (ENRICA)

Cardiovascular Disease

Spain
Yizhou Zheng

Unknown

A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic Anemia (OSP)

Aplastic Anemia

China
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Mackay Memorial Hospital; China Medical... and other collaborators

Completed

A Randomized Study of GEMOX With or Without Cetuximab in Locally Advanced and Metastatic BTC (BTC)

Cholangiocarcinoma | Adenocarcinoma of Gallbladder

Taiwan
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Chang Gung Memorial Hospital; National Cheng-Kung...

Completed

The Study of Metastatic Pancreatic Adenocarcinoma

Metastatic Pancreatic Adenocarcinoma

Taiwan
Biocad

Completed

Pharmacokinetics and Pharmacodynamics Study of BCD-033 Compared to Rebif® in Healthy Volunteers

Healthy

Russian Federation
Rubens Belfort Jr.

Completed

Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema (ATEMD)

Diabetic Macular Edema

Brazil
M.D. Anderson Cancer Center
Celgene Corporation

Completed

Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma

Melanoma

United States
Novavax

Completed

A Phase I Randomized, Observer-Blinded, Dose-Ranging Study in Healthy Subjects 24 to <72 Months of Age

Respiratory Synctial Virus

Canada
Scottish Universities Environmental Research Centre
Biotechnology and Biological Sciences Research Council; University of Glasgow

Completed

Investigating Optimal Propionate Delivery to the Colon Using Stable Isotope Labeling

Optimum Propionate Delivery to the Large Intestine

United Kingdom
Yonsei University

Completed

Impact of an 8-week Linoleic Acid Intake in Soy Oil on Lp-PLA2 Activity in Healthy Adults

Healthy Subjects

Korea, Republic of
Medline Industries

Withdrawn

Comparison of Chitosan and Carboxymethylcellulose Silver Dressings on Burn Wounds in Pediatric and Adult Subjects

Bandages
Vanderbilt University
American Institute of Cancer Prevention

Completed

Effects of Brassica or Indole-3-carbinol on Prostatectomy Patients With PSA Recurrence

Biochemical Failure

United States
Medical University of South Carolina
Genzyme, a Sanofi Company

Completed

Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists

End Stage Renal Disease

United States
Baylor College of Medicine
The Methodist Hospital Research Institute; Center for Cell and Gene Therapy...

Terminated

Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia

Aplastic Anemia

United States
Tufts Medical Center
National Heart, Lung, and Blood Institute (NHLBI); Sinai Hospital of Baltimore

Completed

Safety Study of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors

Vascular Disease | Coronary Artery Disease Risk Factors Multiple

United States
Novartis Vaccines

Completed

Novartis Vaccine and Diagnostics Carriage Trial

N. Meningitidis Carriage

United Kingdom
Massachusetts General Hospital
Pfizer; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center

Completed

Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma | Neoplasm Metastases

United States
Ege University

Completed

Effect of Caffeic Acid Phenethyl Ester as a Matrix Metalloproteinase Inhibitor: Randomized Controlled Clinical Trial

Composite Resins | Matrix Metalloproteinase Inhibitors
Shaare Zedek Medical Center

Completed

The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients

Critical Illness | Venous Thrombosis

Israel
BioLeaders Corporation

Completed

Efficacy and Safety Study of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3)

Cervical Intraepithelial Neoplasia

Korea, Republic of
Seoul National University Hospital
Ministry of Food and Drug Safety, Korea

Completed

Identification of Drug-drug Interaction Between Tacrolimus and Mycophenolate Mofetil in Healthy Adults

Healthy Volunteers

Korea, Republic of
Supplement Formulators, Inc.
Sigma Tau HealthScience LLC; TSI Health Sciences, Inc.

Completed

Comparing Blood Sugar Levels and Endothelial Function of PEAK ATP® With GlycoCarn®, PEAK ATP® and GlycoCarn® Supplements

Endothelial Function | Blood Sugar

United States
Sanofi Pasteur, a Sanofi Company

Completed

A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Phase IV Trial to Collect Safety Data and Sera in Healthy Children Given Fluzone Vaccine

Influenza

United States
Cliniques universitaires Saint-Luc- Université...

Completed

Efficacy and Safety of the Mammalian Target of Rapamycin (mTor Rapamycin) Inhibitor in Vascular Malformations (vasca-LM)

Cardiovascular Abnormalities

Belgium
Sanofi Pasteur, a Sanofi Company

Completed

Study of Safety and Immunogenicity of Fluzone® in Healthy Children

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years

Influenza | Swine-origin A/H1N1 Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of the 2005-2006 Fluzone® Vaccine

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Annual Study for Serum Collection for Immunogenicity and Safety Evaluation in Healthy Children Receiving Fluzone®

Influenza | Orthomyxoviridae Infections

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study to Determine a Preference for Fluzone Vaccine Given Intradermally (ID) and Intramuscularly (IM) in Healthy Adults

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Phase IV Trial to Determine the Safety and Immunogenicity of the WHO Formulation of the 2006-2007 Fluzone® Vaccine

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Trial to Collect Safety Data and Sera for Immunogenicity Testing

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of the World Health Organization (WHO) Formulation of the 2004-2005 Fluzone® Vaccine

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation.

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM

Influenza

United States, Puerto Rico
Sanofi Pasteur, a Sanofi Company

Completed

Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in Adults

Influenza | Orthomyxoviridae Infection | Myxovirus Infection

United States, Puerto Rico
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly

Influenza | Orthomyxoviridae Infection | Myxovirus Infection

United States
Sanofi Pasteur, a Sanofi Company

Completed

Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine

Influenza

United States

Search clinical trials for: amendement du facteur C5 du complément

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations